These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 35941721

  • 1. Immunohistochemical Approach to Genetic Subtyping of Anaplastic Large Cell Lymphoma.
    Feldman AL, Oishi N, Ketterling RP, Ansell SM, Shi M, Dasari S.
    Am J Surg Pathol; 2022 Nov 01; 46(11):1490-1499. PubMed ID: 35941721
    [Abstract] [Full Text] [Related]

  • 2. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M.
    Am J Surg Pathol; 2021 Apr 01; 45(4):550-557. PubMed ID: 33165091
    [Abstract] [Full Text] [Related]

  • 3. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Chen BJ, Hsieh SM, Hsieh TH, Jhuang JY, Kao YC.
    Hum Pathol; 2024 Aug 01; 150():58-66. PubMed ID: 38971328
    [Abstract] [Full Text] [Related]

  • 4. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.
    Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770
    [Abstract] [Full Text] [Related]

  • 5. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.
    Am J Surg Pathol; 2016 Jan 28; 40(1):36-43. PubMed ID: 26379151
    [Abstract] [Full Text] [Related]

  • 6. ALK-Negative Anaplastic Large Cell Lymphoma (ALCL): Prognostic Implications of Molecular Subtyping and JAK-STAT Pathway.
    Parkhi M, Bal A, Das A, Kashyap D, Bhardwaj S, Prakash G, Malhotra P.
    Appl Immunohistochem Mol Morphol; 2021 Oct 01; 29(9):648-656. PubMed ID: 33901030
    [Abstract] [Full Text] [Related]

  • 7. Anaplastic large cell lymphomas with equivocal DUSP22 FISH results: recommendations for clinical reporting and diagnostic evaluation.
    Fadl A, Oishi N, Shi M, Dasari S, Ansell SM, Ketterling RP, Feldman AL.
    Hum Pathol; 2023 Nov 01; 141():6-14. PubMed ID: 37633531
    [Abstract] [Full Text] [Related]

  • 8. Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.
    Wang X, Boddicker RL, Dasari S, Sidhu JS, Kadin ME, Macon WR, Ansell SM, Ketterling RP, Rech KL, Feldman AL.
    Hum Pathol; 2017 Jun 01; 64():19-27. PubMed ID: 28153507
    [Abstract] [Full Text] [Related]

  • 9. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C, Chen X, Chen XY, He YH.
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct 08; 48(10):791-795. PubMed ID: 31594044
    [Abstract] [Full Text] [Related]

  • 10. ALK-negative anaplastic large cell lymphoma with DUSP22 rearrangement has distinctive disease characteristics with better progression-free survival: a LYSA study.
    Sibon D, Bisig B, Bonnet C, Poullot E, Bachy E, Cavalieri D, Fataccioli V, Bregnard C, Drieux F, Bruneau J, Lemonnier F, Dupuy A, Bossard C, Parrens M, Bouabdallah K, Ketterer N, Berthod G, Cairoli A, Damaj G, Tournilhac O, Jais JP, Gaulard P, De Leval L.
    Haematologica; 2023 Jun 01; 108(6):1590-1603. PubMed ID: 36453105
    [Abstract] [Full Text] [Related]

  • 11. JAK/STAT3 Signaling Activation Related to Distinct Clinicopathologic Features in Systemic ALK - Anaplastic Large Cell Lymphomas : New Insights into Their Heterogeneity.
    Wang JC, Zhong LH, Lin WQ, Zhang WF, Xi YF, Liu YP, Zhu Q, Liu W, Zhu WF, Chen YP, Chen G.
    Am J Surg Pathol; 2023 Jan 01; 47(1):55-64. PubMed ID: 36315833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
    Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J.
    Haematologica; 2023 Jun 01; 108(6):1604-1615. PubMed ID: 36453104
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.
    Magaki S, Satyadev R, Chen Z, Yung KS, Vinters HV, Kinney MC, Said JW.
    Brain Tumor Pathol; 2022 Jan 01; 39(1):25-34. PubMed ID: 34791573
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors for primary cutaneous anaplastic large-cell lymphoma: a multicentre retrospective study from Japan.
    Miyagaki T, Inoue N, Kamijo H, Boki H, Takahashi-Shishido N, Suga H, Shimauchi T, Kiyohara E, Hirai Y, Yonekura K, Takeuchi K, Sugaya M.
    Br J Dermatol; 2023 Oct 25; 189(5):612-620. PubMed ID: 37539944
    [Abstract] [Full Text] [Related]

  • 17. Systemic ALK-negative anaplastic large cell lymphoma with NPM1::TYK2 rearrangement.
    Johnson M, Willard N, Pan Z.
    J Hematop; 2024 Dec 25; 17(4):265-270. PubMed ID: 39207720
    [Abstract] [Full Text] [Related]

  • 18. Expression of the chemokine receptor gene, CCR8, is associated With DUSP22 rearrangements in anaplastic large cell lymphoma.
    Xing X, Flotte TJ, Law ME, Blahnik AJ, Chng WJ, Huang G, Knudson RA, Ketterling RP, Porcher JC, Ansell SM, Sidhu J, Dogan A, Feldman AL.
    Appl Immunohistochem Mol Morphol; 2015 Sep 25; 23(8):580-9. PubMed ID: 25390351
    [Abstract] [Full Text] [Related]

  • 19. Genetics of anaplastic large cell lymphoma.
    Zeng Y, Feldman AL.
    Leuk Lymphoma; 2016 Sep 25; 57(1):21-7. PubMed ID: 26104084
    [Abstract] [Full Text] [Related]

  • 20. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X, Feldman AL.
    Adv Anat Pathol; 2015 Jan 25; 22(1):29-49. PubMed ID: 25461779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.